Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

52
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
52
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

54
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
54
Intellectual Disability01:29

Intellectual Disability

239
Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
239
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

559
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
559
Drug Therapy01:28

Drug Therapy

130
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
130
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

284
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
284

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Experiences of stigma in children with long COVID.

Pediatric research·2026
Same author

Police Stops Among Adolescents With Intellectual and Developmental Disabilities: Implications for Traumatic Stress.

Journal of autism and developmental disorders·2026
Same author

Daily Living Skill Profiles in Adolescents With Autism and Developmental Disabilities.

JAMA pediatrics·2026
Same author

Police Contact and Mental Health Among Adolescents With Autism: Findings From the UK Millennium Cohort Study.

The Journal of adolescent health : official publication of the Society for Adolescent Medicine·2025
Same author

Associations between emotion and behavior codes and ADOS-2 scores in a sample of children referred for autism evaluation.

Autism : the international journal of research and practice·2025
Same author

Enhancing Pediatric Long COVID Care Through Telementoring: Insights From an ECHO Program.

Clinical pediatrics·2025

Related Experiment Video

Updated: Oct 30, 2025

Development of a Virtual Reality Assessment of Everyday Living Skills
10:32

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

18.7K

Psychiatric Presentations and Medication Use in Older Adults With Intellectual and Developmental Disabilities.

Elizabeth Wise1, Calliope Holingue2, Ann Klein3

  • 1Department of Psychiatry and Behavioral Sciences (EW), Johns Hopkins University School of Medicine, Baltimore, MD.

The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|July 2, 2021
PubMed
Summary

Older adults with intellectual and developmental disabilities (IDD) experience more medical conditions and polypharmacy, despite fewer psychiatric diagnoses. This highlights an urgent need for focused healthcare attention on this vulnerable population.

Keywords:
Intellectual and developmental disabilitiespsychopathologyservice use

More Related Videos

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

7.5K
Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
10:13

Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach

Published on: February 14, 2014

13.9K

Related Experiment Videos

Last Updated: Oct 30, 2025

Development of a Virtual Reality Assessment of Everyday Living Skills
10:32

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

18.7K
Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

7.5K
Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
10:13

Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach

Published on: February 14, 2014

13.9K

Area of Science:

  • Gerontology
  • Developmental Disabilities
  • Psychiatry

Background:

  • Adults with intellectual and developmental disabilities (IDD) are living longer.
  • Research on the medical and psychiatric needs of older adults with IDD is limited.
  • Age-related differences in mental health presentations require further investigation.

Purpose of the Study:

  • To assess age-related differences in mental health presentations among adults with IDD.
  • To compare the health profiles of younger (30-49 years) and older (50+ years) adults with IDD.

Main Methods:

  • Utilized deidentified data from the START Information Reporting System.
  • Included psychiatric diagnoses, service use, stressors, and behaviors.
  • Employed statistical analyses (t-tests, Mann Whitney U, chi-squared, logistic regression) for group comparisons.

Main Results:

  • Older adults with IDD had more medical conditions than younger adults.
  • Older adults were more likely to be on higher numbers of psychiatric medications.
  • Fewer psychiatric diagnoses were reported in older adults compared to younger adults.

Conclusions:

  • Older adults with IDD present with more medical comorbidities and polypharmacy.
  • Despite fewer reported psychiatric diagnoses, older adults with IDD are at risk.
  • Increased clinical and research focus is needed for the healthcare of older adults with IDD.